Two new flavanes and bioactive compounds from Daphne tangutica Maxim

Natural Product Research

Volumn 21, Issue 11, 2007, Pages 1021-1026

  Zhang, W ^a   Shen, Y H ^a   Lou, Z Y ^a   Liu, R H ^a   Zhang, C ^a   Fu, P ^a   Shan, L ^a   Zhang, W D ^a,b  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Antitumor activity; Daphne tangutica Maxim; Daphneflavan B; Daphneflavan C; Daphnodorin D1; Daphnodorin D2

Indexed keywords

BIFLAVONOID; CYCLOPHOSPHAMIDE; DAPHNE TANGUTICA EXTRACT; DAPHNEFLAVAN B; DAPHNEFLAVAN C; DAPHNODORIN D1; DAPHNODORIN D2; FLAVANE DERIVATIVE; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DAPHNE; DAPHNE TANGUTICA; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PLANT ROOT; PROTON NUCLEAR MAGNETIC RESONANCE; SARCOMA;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DAPHNE; DRUG SCREENING ASSAYS, ANTITUMOR; DRUGS, CHINESE HERBAL; FEMALE; FLAVONOIDS; MICE; MOLECULAR STRUCTURE; PLANT ROOTS; PLANTS, MEDICINAL;

DAPHNE;

EID: 34547960395     PISSN: 14786419     EISSN: 14786427     Source Type: Journal    
DOI: 10.1080/14786410701371603     Document Type: Article

References (6)

1. Torrance, SJ, Hoffmann, JJ and Cole, JR (2004) J. Pharm. Sci., 68, p. 664.
2. Hall, IH, Tagahara, K. and Lee, KH (1982) J. Pharm. Sci., 71, p. 741.
3. Song, LR (1999) China Herbal, 5, p. 407.
4. Li, SH, Hu, LJ and Yin, HY (2002) China J. Chin. Mater. Med., 27, p. 401.
5. Torres, SL, Monteriro, JC and Arruda, MS (1997) Phytochemistry, 44, p. 347.
6. Masahiko, T., Akiko, F. and Kimiye, B. (1997) Phytochemistry, 45, p. 183.